{"id":10326,"date":"2025-07-21T15:45:29","date_gmt":"2025-07-21T13:45:29","guid":{"rendered":"https:\/\/syva.es\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/"},"modified":"2025-07-21T16:34:05","modified_gmt":"2025-07-21T14:34:05","slug":"o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa","status":"publish","type":"post","link":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/","title":{"rendered":"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa"},"content":{"rendered":"<h3><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syvazul\u00ae BTV 3 recebe um parecer favor\u00e1vel do CVMP para a administra\u00e7\u00e3o de 2 ml em bovinos.<\/span><\/h3>\n<p><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Le\u00f3n, 21 de julho de 2025 <\/span><\/strong> <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">\u2013 A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um<\/span><strong><a class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-underline text-strikethrough-none\" draggable=\"false\" href=\"https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-committee-veterinary-medicinal-products-cvmp-15-17-july-2025\" target=\"_blank\" rel=\"noopener\"> parecer favor\u00e1vel<\/a><\/strong>, r<span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ecomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">A principal varia\u00e7\u00e3o <strong>\u00e9 <\/strong><\/span><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml,<\/span> <\/strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>o <\/strong>que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">A indica\u00e7\u00e3o proposta \u00e9 a imuniza\u00e7\u00e3o ativa de bovinos para reduzir a viremia causada pelo serotipo 3 do v\u00edrus da l\u00edngua azul, utilizando um esquema vacinal<\/span> <strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">de duas injec\u00e7\u00f5es intramusculares de 2 ml administradas com um intervalo de tr\u00eas semanas.<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syvazul\u00ae BTV 3 est\u00e1 actualmente autorizado para la inmunizaci\u00f3n activa de los <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">ovinos<\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"> para reducir la viremia, la mortalidad, los signos cl\u00ednicos y las lesiones causadas por el serotipo 3 del virus de la lengua azul, utilizando un calendario de vacunaci\u00f3n de <\/span><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>una inyecci\u00f3n subcut\u00e1nea de 2 ml a partir de los 3 meses de edad<\/strong>.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um parecer favor\u00e1vel, recomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3. A principal varia\u00e7\u00e3o \u00e9 a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml, o que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes. <\/p>\n","protected":false},"author":4,"featured_media":10322,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[2224,1530,2043,1518,1525],"tags":[2234,2239,2343,2238,2225,2117],"class_list":["post-10326","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicado-de-prensa-pt-pt","category-corporate-pt-pt","category-en-foco-pt-pt","category-sem-categoria","category-syva-no-mundo","tag-bovinos-pt-pt","tag-btv3-pt-pt","tag-europa-pt-pt","tag-lengua-azul-pt-pt","tag-salud-animal-pt-pt","tag-vacina"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa - Syva<\/title>\n<meta name=\"description\" content=\"A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um parecer favor\u00e1vel, recomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3. A principal varia\u00e7\u00e3o \u00e9 a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml, o que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa - Syva\" \/>\n<meta property=\"og:description\" content=\"A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um parecer favor\u00e1vel, recomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3. A principal varia\u00e7\u00e3o \u00e9 a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml, o que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/\" \/>\n<meta property=\"og:site_name\" content=\"Syva\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-21T13:45:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-21T14:34:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION-1110x624.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1110\" \/>\n\t<meta property=\"og:image:height\" content=\"624\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Caroline De Siron\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline De Siron\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/\"},\"author\":{\"name\":\"Caroline De Siron\",\"@id\":\"https:\/\/syva.es\/pt-pt\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\"},\"headline\":\"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa\",\"datePublished\":\"2025-07-21T13:45:29+00:00\",\"dateModified\":\"2025-07-21T14:34:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/\"},\"wordCount\":217,\"publisher\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/#organization\"},\"image\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"keywords\":[\"Bovinos\",\"BTV3\",\"Europa\",\"Lengua Azul\",\"Salud animal\",\"vacina\"],\"articleSection\":{\"0\":\"Comunicado de prensa\",\"1\":\"Corporate\",\"2\":\"En Foco\",\"4\":\"Syva no mundo\"},\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/\",\"url\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/\",\"name\":\"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa - Syva\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"datePublished\":\"2025-07-21T13:45:29+00:00\",\"dateModified\":\"2025-07-21T14:34:05+00:00\",\"description\":\"A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um parecer favor\u00e1vel, recomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3. A principal varia\u00e7\u00e3o \u00e9 a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml, o que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes.\",\"breadcrumb\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/syva.es\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/syva.es\/pt-pt\/#website\",\"url\":\"https:\/\/syva.es\/pt-pt\/\",\"name\":\"Syva\",\"description\":\"Soluciones con sentido para la salud animal\",\"publisher\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/syva.es\/pt-pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/syva.es\/pt-pt\/#organization\",\"name\":\"Syva\",\"url\":\"https:\/\/syva.es\/pt-pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/syva.es\/pt-pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"width\":512,\"height\":512,\"caption\":\"Syva\"},\"image\":{\"@id\":\"https:\/\/syva.es\/pt-pt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/syva.es\/pt-pt\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\",\"name\":\"Caroline De Siron\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/syva.es\/pt-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"caption\":\"Caroline De Siron\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa - Syva","description":"A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um parecer favor\u00e1vel, recomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3. A principal varia\u00e7\u00e3o \u00e9 a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml, o que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/","og_locale":"pt_PT","og_type":"article","og_title":"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa - Syva","og_description":"A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um parecer favor\u00e1vel, recomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3. A principal varia\u00e7\u00e3o \u00e9 a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml, o que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes.","og_url":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/","og_site_name":"Syva","article_published_time":"2025-07-21T13:45:29+00:00","article_modified_time":"2025-07-21T14:34:05+00:00","og_image":[{"width":1110,"height":624,"url":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION-1110x624.png","type":"image\/png"}],"author":"Caroline De Siron","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Caroline De Siron","Tempo estimado de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#article","isPartOf":{"@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/"},"author":{"name":"Caroline De Siron","@id":"https:\/\/syva.es\/pt-pt\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052"},"headline":"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa","datePublished":"2025-07-21T13:45:29+00:00","dateModified":"2025-07-21T14:34:05+00:00","mainEntityOfPage":{"@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/"},"wordCount":217,"publisher":{"@id":"https:\/\/syva.es\/pt-pt\/#organization"},"image":{"@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","keywords":["Bovinos","BTV3","Europa","Lengua Azul","Salud animal","vacina"],"articleSection":{"0":"Comunicado de prensa","1":"Corporate","2":"En Foco","4":"Syva no mundo"},"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/","url":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/","name":"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa - Syva","isPartOf":{"@id":"https:\/\/syva.es\/pt-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage"},"image":{"@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","datePublished":"2025-07-21T13:45:29+00:00","dateModified":"2025-07-21T14:34:05+00:00","description":"A Syva tem o prazer de anunciar que, em 17 de julho de 2025, o Comit\u00e9 de Medicamentos de Uso Veterin\u00e1rio (CVMP) emitiu um parecer favor\u00e1vel, recomendando a aprova\u00e7\u00e3o de uma varia\u00e7\u00e3o das condi\u00e7\u00f5es da autoriza\u00e7\u00e3o de introdu\u00e7\u00e3o no mercado da vacina Syvazul\u00ae BTV 3. A principal varia\u00e7\u00e3o \u00e9 a inclus\u00e3o da esp\u00e9cie bovina com uma dose de 2 ml, o que melhora a conveni\u00eancia e est\u00e1 em conformidade com os dados regulamentares mais recentes.","breadcrumb":{"@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#primaryimage","url":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2025\/07\/COMUNICADO-DE-PRENSA-SYVAZUL-BTV3-CVMP-POSITIVE-OPINION.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/syva.es\/pt-pt\/o-cvmp-emite-um-parecer-favoravel-para-o-syvazul-btv3-na-europa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/syva.es\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"O CVMP emite um parecer favor\u00e1vel para o Syvazul\u00ae BTV3 na Europa"}]},{"@type":"WebSite","@id":"https:\/\/syva.es\/pt-pt\/#website","url":"https:\/\/syva.es\/pt-pt\/","name":"Syva","description":"Soluciones con sentido para la salud animal","publisher":{"@id":"https:\/\/syva.es\/pt-pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/syva.es\/pt-pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/syva.es\/pt-pt\/#organization","name":"Syva","url":"https:\/\/syva.es\/pt-pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/syva.es\/pt-pt\/#\/schema\/logo\/image\/","url":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","width":512,"height":512,"caption":"Syva"},"image":{"@id":"https:\/\/syva.es\/pt-pt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/syva.es\/pt-pt\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052","name":"Caroline De Siron","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/syva.es\/pt-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","caption":"Caroline De Siron"}}]}},"modified_by":null,"_links":{"self":[{"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/posts\/10326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/comments?post=10326"}],"version-history":[{"count":0,"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/posts\/10326\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/media\/10322"}],"wp:attachment":[{"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/media?parent=10326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/categories?post=10326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/syva.es\/pt-pt\/wp-json\/wp\/v2\/tags?post=10326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}